Press Releases

INTERPHEX 2024 Concludes with Major Success Showcasing Innovation, Knowledge Capture and Networking

Norwalk, US -- 23 April 2024 –– INTERPHEX, the premier, global pharmaceutical and
biotechnology trade event concluded last week (16-18 April 2024) following three days of scientifically curated discussions, daily networking events, and new product and innovative discovery. INTERPHEX welcomed 9,000+ industry professionals – from scientists and researchers, to processing and manufacturing engineers – representing all facets of the pharmaceutical product development lifecycle. The Javits Center was buzzing with 500+ exhibitors showcasing best practices and innovation that fueled business growth and scalability for visitors.

A major highlight of INTERPHEX 2024 was the brand new INTERPHEX Conference located in the transformative Learning Lab – a destination on the Show Floor that featured 90+ curated education sessions in partnership with the American Association of Pharmaceutical Scientists (AAPS) and a 2024 Scientific Programming Advisory Committee, led by Conference Chair, Carl Allenspach, PhD, Chief of Staff of Manufacturing Science and Technology of Bristol Myers Squibb and Conference Vice Chair, William E Weiser, PhD, Senior Director, Global Quality Systems of Thermo Fisher Scientific.

The Learning Lab – an enclosed, private education space reserved for Full Conference badge holders – consisted of an enriched meeting experience with innovative headset technology to tune into one of three stages, a Career Center with a professional headshot photobooth and a resume review area, and campfire sessions featuring FDA speakers highlighting best practices and insights for FDA approvals. Other amenities of the Learning Lab included catered lunches, additional meeting space, and an exclusive Networking Reception.

INTERPHEX Conference showcased everything from AI/Machine Learning, Continuous
Processing and Manufacturing Developments, Compliance, Supply Chain, Cell and Gene Therapy, and so much more, explored through Keynotes, Panel Discussions, Quick Fires, and Late Breaking Sessions.

Additional Show Floor Content was also available for all badge holders on the popular
INTERPHEX Live, Contract Stage, and Technical Theaters.

INTERPHEX TV, a news studio highlighting features of the event, debuted on the Show Floor conducting interviews with exhibitors, speakers, and visitors with topics ranging from product launches, new trends, education programming sneak peeks, the future of pharmaceuticals, and much more. Video interviews can be watched here >>

"INTERPHEX 2024 has once again proven to be a dynamic platform where the pharmaceutical and biotechnology industries converge to showcase cutting-edge innovations and exchange invaluable knowledge,” says Douglas Lugo, INTERPHEX Event Director. “This year's event, with its diverse range of exhibitors and curated educational sessions, highlights the ongoing dedication to advancement within our field. The newly introduced INTERPHEX Conference, in particular, provided an immersive learning experience, fostering insightful discussions and paving the way for future advancements. As we reflect on the success of INTERPHEX 2024, it is evident that collaboration, innovation, and a commitment to excellence will continue to drive our industry forward."

This year’s Show Floor was packed with exhibitor innovation and leading technology. The INTERPHEX Exhibitor Awards honored advancements in technology-development, efficiency, and up-and-coming innovation. Sponsored and reviewed by American Pharmaceutical Review and Pharmaceutical Outsourcing, award categories and winners for 2024 include:
• Best in Show: AST Inc. – GENiSYS C
• Best New Product/Service: IMA Group – KryoAir: Pioneering Sustainable Refrigeration
• Editor’s Choice: KORSCH America Inc. – X 5 Tablet Press
• Best Technologies Innovation: AustinPX, Pharmaceutics and Manufacturing – Kinetisol
• INTERPHEX Efficiency Champion: ConSynSys Technologies, Inc. – The ProCaaSo™ Platform
• Biotech Innovation Award: IDEX MPT, Inc. – The MP350 Microlyser™ Processor

Planning for INTERPHEX 2025 is already underway. The show will return to the Javits Center, 1-3 April 2025. For more information about our 2025 Show and to be notified when registration becomes available next year, fill out our registration inquiry form.

INTERPHEX is the premier pharmaceutical, biotechnology, and device development and manufacturing event where you can “Experience Science through Commercialization.” The event is based in New York and brings approximately 8,000+ global industry professionals and industry leading suppliers together through a unique combination of exhibits, demonstrations, partnering opportunities, networking and a curated INTERPHEX Conference in the Learning Lab to leverage quality, efficiency, and cost effectiveness in today’s ever-changing global market. Follow INTERPHEX on Facebook, LinkedIn, YouTube, and Twitter. For more information, visit

About RX (Reed Exhibitions)
RX is a global leader in events and exhibitions, leveraging industry expertise, data and
technology to build businesses for individuals, communities and organizations. With a
presence in 25 countries across 42 industry sectors, RX hosts approximately 350 events annually. RX is committed to creating an inclusive work environment for all our people. RX empowers businesses to thrive by leveraging data-driven insights and digital solutions. RX is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit

About RELX
RELX is a global provider of information-based analytics and decision tools for professional and business customers. RELX serves customers in more than 180 countries and has offices in about 40 countries. It employs more than 36,000 people over 40% of whom are in North America. The shares of RELX PLC, the parent company, are traded on the London, Amsterdam and New York stock exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX